Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actimed, Assertio, Bicycle, Corcept, Incyclix, Iteos, Jaguar, Repare.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Icecure, Mannkind, Reprieve Cardiovascular.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Blue Lake, Briacell, Caliway, Corcept, Eli Lilly, Halia, Immutep, Keros, Kiromic, Krystal, Merck, Ose  Immunotherapeutics, Pfizer.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Centinel Spine, Lunit, Sensome, Zynex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelyrin, ADC, Anaptysbio, Arrowhead, Astria, Candel, Dizal, Ionctura, Minoryx, Moberg, Pharming, Q32, Horizon, Scilex, Siga, Sound, Spruce.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agendia, Immunovia, Skylinedx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Affimed, ALX, Arvinas, Atyr, Biomea, Cardiff, Cervomed, Daré, Grin, Ichnos, Immix, Immune-Onc, Keros, Lyell, Immunopharma, Maat, Nanobiotix, Newamsterdam, Nurix, Olema, Pfizer, Recursion, Regeneron, Rigel, Sellas, Sumitomo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aavantgarde, Abbvie, Agios, Alzinova, Arcellx, Artelo, Astrazeneca, Bioage Labs, Bionomics, Cogent, Delta-Fly, Enanta, Incyte, Innate, Mendus, Merck, Mymd, Neurona, Novo Nordisk, Rapport, Sonnet, Stoke, Theratechnologies, Tiakis, Vivoryon, Vor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Volitionrx.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Astrazeneca, Cynata Therapeutics, Everest, Hua Medicine, Inventisbio, MEsoblast Vasomune Therapeutics.